Skip to main content
Log in

Oral gold (auranofin) in juvenile rheumatoid arthritis: A 48-week phase II study

  • Letters
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dequeker, J., Van de Venne, H. (editors). Proceedings Symposium Auranofin. Clin Rheumatol, 1984, 3, Suppl. n∘ 1.

  2. Kvien, T.K., Høyeraal, H.M., Kåss, E. Diagnostic criteria of rheumatoid arthritis in children. Proposed criteria for controlled clinical studies. Scand J Rheumatol, 1982, 11, 187–192.

    Article  PubMed  CAS  Google Scholar 

  3. Kvien, T.K., Høyeraal, H.M., Sandstad, B. Assessment methods of disease activity in juvenile rheumatoid arthritis — evaluated in a prednisolone/ placebo double-blind study. J Rheumatol, 1982, 9, 696–702.

    PubMed  CAS  Google Scholar 

  4. Giannini, E.H., Brewer, E.J., Person, D.A. Auranofin in the treatment of juvenile rheumatoid arthritis. J Pediatr, 1983, 102, 138–141.

    Article  PubMed  CAS  Google Scholar 

  5. Lewis, D., Capell, H.A., McNeil, C.J., Iqbal, M.S., Brown, D.H., Smith, W.E. Gold levels produced by treatment with auranofin and sodium aurothiomalate. Ann Rheum Dis, 1983, 42, 566–570.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kvien, T.K., Høyeraal, H.M., Sandstad, B. et al. Oral gold (auranofin) in juvenile rheumatoid arthritis: A 48-week phase II study. Clin Rheumatol 3, 551–552 (1984). https://doi.org/10.1007/BF02031282

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02031282

Keywords

Navigation